View in EDS HTML Full Text PDF Full Text

Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate‐risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006‐intermediate‐risk trial

Saved in:
Bibliographic Details
Title: Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate‐risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006‐intermediate‐risk trial
Authors: Bouvier, Anne1 (AUTHOR), Hamel, Jean‐François2 (AUTHOR), Delaunay, Jacques3 (AUTHOR), Delabesse, Eric4 (AUTHOR), Dumas, Pierre‐Yves5 (AUTHOR), Ledoux, Marie‐Pierre6 (AUTHOR), Peterlin, Pierre3 (AUTHOR), Luquet, Isabelle4 (AUTHOR), Roth Guepin, Gabrielle7 (AUTHOR), Bulabois, Claude Eric8 (AUTHOR), Gallego Hernanz, Maria Pilar9 (AUTHOR), Guillerm, Gaëlle10 (AUTHOR), Guieze, Romain11 (AUTHOR), Hicheri, Yosr12 (AUTHOR), Simand, Célestine13 (AUTHOR), Himberlin, Chantal14 (AUTHOR), Hunault‐Berger, Mathilde15 (AUTHOR), Bernard, Marc16 (AUTHOR), Jourdan, Eric17 (AUTHOR), Caillot, Denis18 (AUTHOR)
Source: European Journal of Haematology. Jul2021, Vol. 107 Issue 1, p111-121. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09024441
DOI:10.1111/ejh.13626